• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell Mol Life Sci . SARS-CoV2 infection in whole lung primarily targets macrophages that display subset-specific responses

tetano

Editor, Senior Moderator
Cell Mol Life Sci


. 2024 Aug 15;81(1):351.
doi: 10.1007/s00018-024-05322-z. SARS-CoV2 infection in whole lung primarily targets macrophages that display subset-specific responses

Thien-Phong Vu Manh[SUP] 1 [/SUP], Carla Gouin[SUP] #[/SUP][SUP] 2 [/SUP], Julien De Wolf[SUP] #[/SUP][SUP] 2 3 [/SUP], Luc Jouneau[SUP] #[/SUP][SUP] 2 4 [/SUP], Florentina Pascale[SUP] 2 3 [/SUP], Claudia Bevilacqua[SUP] 5 [/SUP], Meriadeg Ar Gouilh[SUP] 6 [/SUP], Bruno Da Costa[SUP] 2 [/SUP], Christophe Chevalier[SUP] 2 [/SUP], Matthieu Glorion[SUP] 2 3 [/SUP], Laurent Hannouche[SUP] 7 2 [/SUP], Céline Urien[SUP] 2 [/SUP], Jérôme Estephan[SUP] 2 [/SUP], Antoine Magnan[SUP] 2 8 [/SUP], Morgan Le Guen[SUP] 2 9 [/SUP], Quentin Marquant[SUP] 2 8 10 [/SUP], Delphyne Descamps[SUP] 2 [/SUP], Marc Dalod[SUP] 7 [/SUP], Isabelle Schwartz-Cornil[SUP] 11 [/SUP], Edouard Sage[SUP] 2 3 [/SUP]



Affiliations
Abstract

Deciphering the initial steps of SARS-CoV-2 infection, that influence COVID-19 outcomes, is challenging because animal models do not always reproduce human biological processes and in vitro systems do not recapitulate the histoarchitecture and cellular composition of respiratory tissues. To address this, we developed an innovative ex vivo model of whole human lung infection with SARS-CoV-2, leveraging a lung transplantation technique. Through single-cell RNA-seq, we identified that alveolar and monocyte-derived macrophages (AMs and MoMacs) were initial targets of the virus. Exposure of isolated lung AMs, MoMacs, classical monocytes and non-classical monocytes (ncMos) to SARS-CoV-2 variants revealed that while all subsets responded, MoMacs produced higher levels of inflammatory cytokines than AMs, and ncMos contributed the least. A Wuhan lineage appeared to be more potent than a D614G virus, in a dose-dependent manner. Amidst the ambiguity in the literature regarding the initial SARS-CoV-2 cell target, our study reveals that AMs and MoMacs are dominant primary entry points for the virus, and suggests that their responses may conduct subsequent injury, depending on their abundance, the viral strain and dose. Interfering on virus interaction with lung macrophages should be considered in prophylactic strategies.

Keywords: 10X genomics; Azimuth software; Ex vivo lung perfusion; Viral nebulization.

 
Back
Top Bottom